{
    "eid": "2-s2.0-85153334404",
    "title": "Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "levodopa",
        "monoamine oxidase B inhibitor",
        "motor fluctuation",
        "Parkinson's disease",
        "post hoc analysis",
        "safinamide",
        "treatment response"
    ],
    "authors": [
        "Roongroj Bhidayasiri",
        "Michinori Koebis",
        "Takanori Kamei",
        "Takayuki Ishida",
        "Ippei Suzuki",
        "Jin Whan Cho",
        "Shey Lin Wu"
    ],
    "citedby-count": 0,
    "ref-count": 38,
    "ref-list": [
        "Pathophysiology of the basal ganglia in Parkinson's disease",
        "Parkinson Study Group. Determination of minimal clinically important change in early and advanced Parkinson's disease",
        "Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire",
        "Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review",
        "Parkinson's disease therapy [colon] tailoring choices for early and late disease, young and old patients",
        "Rasagiline adjunct therapy in patients with Parkinson's disease: post hoc analyses of the PRESTO and LARGO trials",
        "Safinamide as add-on therapy to levodopa in mid- to late-stage parkinson's disease fluctuating patients: post hoc analyses of studies 016 SETTLE",
        "Efficacy of rotigotine at different stages of parkinson's disease symptom severity and disability: a post hoc analysis according to baseline hoehn and yahr stage",
        "The added benefit of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: a post-hoc analysis of BIPARK-I -II",
        "Pooled analysis from phase 2b and 3 studies in japan of Istradefylline in Parkinson's disease",
        "Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics",
        "Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study",
        "Dopamine gene profiling to predict impulse control and effects of dopamine agonist ropinirole",
        "Comparative whole transcriptome analysis of Parkinson's disease focusing on the efficacy of zonisamide",
        "Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia",
        "Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations",
        "Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial",
        "Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: a randomized, double-blind, placebo-controlled, phase II/III study",
        "The XINDI Study: a randomized phase iii clinical trial evaluating the efficacy and safety of safinamide as add-on therapy to levodopa in Chinese patients with Parkinson's disease with motor fluctuations",
        "Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta-analysis of randomized controlled trials",
        "Overall efficacy and safety of safinamide in parkinson's disease: a systematic review and a meta-analysis",
        "Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial",
        "Opicapone as adjunct to levodopa therapy in patients with parkinson disease and motor fluctuations: a randomized clinical trial",
        "Randomized, controlled study of opicapone in japanese Parkinson's patients with motor fluctuations",
        "Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial",
        "Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release",
        "Predictors of response for \u201cOff\u201d time improvement with levodopa-carbidopa intestinal gel treatment: an analysis of the GLORIA registry",
        "Predictors of the placebo response in clinical trials on Parkinson's disease: a meta-analysis",
        "Long-term effects of safinamide on dyskinesia in mid- to late-stage parkinson's disease: a post-hoc analysis",
        "Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson's disease: post-hoc analysis of a Japanese phase III study",
        "Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts",
        "Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease",
        "Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease",
        "Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in Parkinson's disease",
        "A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients",
        "SP 650 Study Group. Advanced Parkinson disease treated with rotigotine transdermal system: PREFER study",
        "Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: a randomized, double-blind, placebo-controlled pivotal study",
        "Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Tokyo",
            "@id": "60018508",
            "affilname": "Eisai Co., Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018508",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Changhua",
            "@id": "60022174",
            "affilname": "Changhua Christian Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022174",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60020857",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "126790845",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126790845",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Newron Pharmaceuticals",
        "Merck Serono",
        "Eisai Co., Ltd."
    ]
}